KLRB1 and melanoma: Taken together, these findings demonstrate that in a TH1-polarizing tumor microenvironment, CD8+CD161+ T-cells exhibit enhanced cytotoxicity and reduced exhaustion, potentially promoting survival in melanoma patients.